Annual Operating Expenses
$87.53 M
-$16.85 M-16.14%
December 31, 2023
Summary
- As of February 12, 2025, EIGR annual total operating expenses is $87.53 million, with the most recent change of -$16.85 million (-16.14%) on December 31, 2023.
- During the last 3 years, EIGR annual operating expenses has risen by +$25.39 million (+40.85%).
- EIGR annual operating expenses is now -16.14% below its all-time high of $104.39 million, reached on December 31, 2022.
Performance
EIGR Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$16.32 M
-$3.71 M-18.51%
December 31, 2023
Summary
- As of February 12, 2025, EIGR quarterly total operating expenses is $16.32 million, with the most recent change of -$3.71 million (-18.51%) on December 31, 2023.
- Over the past year, EIGR quarterly operating expenses has dropped by -$10.51 million (-39.17%).
- EIGR quarterly operating expenses is now -44.05% below its all-time high of $29.16 million, reached on September 30, 2022.
Performance
EIGR Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
EIGR Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -16.1% | -39.2% |
3 y3 years | +40.9% | -9.2% |
5 y5 years | +71.5% | +1.4% |
EIGR Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -16.1% | at low | -44.0% | at low |
5 y | 5-year | -16.1% | +40.9% | -44.0% | +11.6% |
alltime | all time | -16.1% | +3930.2% | -44.0% | +183.3% |
Eiger BioPharmaceuticals Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Dec 2023 | $87.53 M(-16.1%) | $16.32 M(-18.5%) |
Sep 2023 | - | $20.02 M(-19.7%) |
Jun 2023 | - | $24.93 M(-5.1%) |
Mar 2023 | - | $26.26 M(-2.1%) |
Dec 2022 | $104.39 M(+18.2%) | $26.82 M(-8.0%) |
Sep 2022 | - | $29.16 M(+21.4%) |
Jun 2022 | - | $24.02 M(-1.5%) |
Mar 2022 | - | $24.38 M(+0.9%) |
Dec 2021 | $88.34 M(+42.1%) | $24.17 M(-1.6%) |
Sep 2021 | - | $24.57 M(+21.7%) |
Jun 2021 | - | $20.19 M(+4.0%) |
Mar 2021 | - | $19.41 M(+8.0%) |
Dec 2020 | $62.15 M(-9.8%) | $17.96 M(+21.1%) |
Sep 2020 | - | $14.84 M(+1.4%) |
Jun 2020 | - | $14.63 M(-0.6%) |
Mar 2020 | - | $14.72 M(-10.8%) |
Dec 2019 | $68.90 M(+35.0%) | $16.51 M(-9.8%) |
Sep 2019 | - | $18.31 M(+6.7%) |
Jun 2019 | - | $17.16 M(+1.4%) |
Mar 2019 | - | $16.93 M(+5.2%) |
Dec 2018 | $51.05 M | $16.09 M(-4.4%) |
Sep 2018 | - | $16.84 M(+75.2%) |
Jun 2018 | - | $9.61 M(+13.0%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2018 | - | $8.51 M(-19.6%) |
Dec 2017 | $41.52 M(-10.0%) | $10.59 M(+19.3%) |
Sep 2017 | - | $8.87 M(-19.9%) |
Jun 2017 | - | $11.08 M(+0.8%) |
Mar 2017 | - | $10.99 M(-14.9%) |
Dec 2016 | $46.12 M(+255.5%) | $12.91 M(+13.9%) |
Sep 2016 | - | $11.34 M(-14.1%) |
Jun 2016 | - | $13.20 M(+52.1%) |
Mar 2016 | - | $8.68 M(-144.3%) |
Dec 2015 | $12.97 M(-60.7%) | -$19.59 M(-698.9%) |
Sep 2015 | - | $3.27 M(-74.8%) |
Jun 2015 | - | $12.99 M(-20.3%) |
Mar 2015 | - | $16.30 M(+48.7%) |
Dec 2014 | $33.02 M(+65.4%) | $10.96 M(+34.8%) |
Sep 2014 | - | $8.13 M(+16.1%) |
Jun 2014 | - | $7.00 M(+1.2%) |
Mar 2014 | - | $6.92 M(+15.8%) |
Dec 2013 | $19.96 M(+25.2%) | $5.98 M(+8.2%) |
Sep 2013 | - | $5.52 M(+10.6%) |
Jun 2013 | - | $4.99 M(+43.8%) |
Mar 2013 | - | $3.47 M |
Dec 2012 | $15.95 M(+634.1%) | - |
Dec 2011 | $2.17 M(-64.0%) | - |
Jun 2011 | $6.03 M | - |
FAQ
- What is Eiger BioPharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals annual operating expenses year-on-year change?
- What is Eiger BioPharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals quarterly operating expenses year-on-year change?
What is Eiger BioPharmaceuticals annual total operating expenses?
The current annual operating expenses of EIGR is $87.53 M
What is the all time high annual operating expenses for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high annual total operating expenses is $104.39 M
What is Eiger BioPharmaceuticals annual operating expenses year-on-year change?
Over the past year, EIGR annual total operating expenses has changed by -$16.85 M (-16.14%)
What is Eiger BioPharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of EIGR is $16.32 M
What is the all time high quarterly operating expenses for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high quarterly total operating expenses is $29.16 M
What is Eiger BioPharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, EIGR quarterly total operating expenses has changed by -$10.51 M (-39.17%)